Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,075 | -25,295 | -21,702 | -20,664 | -21,611 |
| Depreciation Amortization | -349 | 7 | 6 | -4 | -7 |
| Other Working Capital | -117 | 655 | -221 | -670 | -524 |
| Other Operating Activity | -3,058 | 9,212 | 10,202 | 13,069 | 17,973 |
| Operating Cash Flow | $-5,598 | $-15,420 | $-11,715 | $-8,268 | $-4,169 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,000 | -9,298 | -6,289 | -9,289 | 714 |
| PPE Investments | -3 | -75 | -21 | -18 | -4 |
| Investing Cash Flow | $2,998 | $-9,373 | $-6,310 | $-9,307 | $710 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 22,114 | 14,673 | 14,787 | 2,366 |
| Financing Cash Flow | $N/A | $22,114 | $14,673 | $14,787 | $2,366 |
| Beginning Cash Position | 8,899 | 11,579 | 11,579 | 11,579 | 11,579 |
| End Cash Position | 6,298 | 8,899 | 8,226 | 8,791 | 10,486 |
| Net Cash Flow | $-2,601 | $-2,679 | $-3,352 | $-2,788 | $-1,092 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,598 | -15,420 | -11,715 | -8,268 | -4,169 |
| Capital Expenditure | -3 | -75 | -21 | -18 | -4 |
| Free Cash Flow | -5,601 | -15,495 | -11,737 | -8,286 | -4,173 |